These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36872421)

  • 21. Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease.
    Raptis V; Georgianos PI; Sarafidis PA; Sioulis A; Makedou K; Makedou A; Grekas DM; Kapoulas S
    Kidney Blood Press Res; 2013; 38(1):72-82. PubMed ID: 24577239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonic characterization (integrated backscatter) of myocardial tissue in patients with autosomal dominant polycystic kidney disease.
    Jin X; Rong S; Mei C; Chen J; Ye C; Chen X
    Nephron Clin Pract; 2010; 114(4):c288-94. PubMed ID: 20090371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases.
    Mahdy A; Stradner M; Roessler A; Brix B; Lackner A; Salon A; Goswami N
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure response after two-step exercise as a powerful predictor of hypertension: the Osaka Health Survey.
    Tsumura K; Hayashi T; Hamada C; Endo G; Fujii S; Okada K
    J Hypertens; 2002 Aug; 20(8):1507-12. PubMed ID: 12172311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of a method of blood pressure measurement for a study of hypertension in a black African population].
    Megnigbeto AC; Niakara A; Nebie LV; Ouédraogo NA; Zagré Nl
    Sante; 2002; 12(3):313-7. PubMed ID: 12473526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease.
    Wang D; Strandgaard S; Borresen ML; Luo Z; Connors SG; Yan Q; Wilcox CS
    Am J Kidney Dis; 2008 Feb; 51(2):184-91. PubMed ID: 18215696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
    Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
    Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
    Ramunni A; Saracino A; Esposito T; Saliani MT; Coratelli P
    Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of post exercise hypotension in normotensive offspring of hypertensives after acute exercise.
    Jain N; Bedi M; Varshney VP
    Indian J Med Res; 2023 Sep; 158(3):311-316. PubMed ID: 37861625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA; Prata MM
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study.
    Singh JP; Larson MG; Manolio TA; O'Donnell CJ; Lauer M; Evans JC; Levy D
    Circulation; 1999 Apr; 99(14):1831-6. PubMed ID: 10199879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
    Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
    Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the effect of internet-based dietary self-management on blood pressure in high-risk population of hypertension in Haikou City community].
    He LM; Yan YX; Zhao CJ; Zhu XL; Liang BF; Lin GT; Chen JC; Zhang F
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1581-1589. PubMed ID: 37859374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
    Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
    J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic Succinate, Hypoxia-Inducible Factor-1 Alpha, and IL-1β Gene Expression in Autosomal Dominant Polycystic Kidney Disease with and without Hypertension.
    Kocyigit I; Taheri S; Eroglu E; Sener EF; Zararsız G; Uzun I; Tufan E; Mehmetbeyoglu E; Korkmaz Bayramov K; Sipahioglu MH; Ozkul Y; Tokgoz B; Oymak O; Axelsson J
    Cardiorenal Med; 2019; 9(6):370-381. PubMed ID: 31319406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of muscle echo intensity on post-exercise blood pressure response in older normotensive and hypertensive females: Pilot study.
    Takeda R; Hirono T; Yoshiko A; Kunugi S; Okudaira M; Ueda S; Watanabe K
    Physiol Rep; 2022 Nov; 10(21):e15514. PubMed ID: 36353930
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.